Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genbase Biologics is a synthetic biology company specializing in high-throughput gene synthesis and intelligent manufacturing for the life sciences sector. Based in Shenzhen, China, the company develops automated platforms and "programmable biology" tools designed to accelerate the discovery and production of cell and gene therapies (CGT). By leveraging advanced algorithms and hardware automation, Genbase aims to optimize the genetic engineering workflow, significantly reducing the costs and timelines associated with complex biologics development. The company serves as a critical technology provider for pharmaceutical and biotechnology firms seeking to develop next-generation therapeutics and mRNA-based products. Genbase has secured substantial backing from major venture capital firms to expand its technological infrastructure and global reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genbase Biologics.